Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylnaltrexone for Opioid Related Constipation in the ED
NCT00949377Phase 4Withdrawn
- Sponsor
- Mount Sinai Beth Israel
- Start
- Sep 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of methylnaltrexone in opioid-induced constipation (OIC), sponsored by Mount Sinai Beth Israel. Planned start Sep 2009; status: withdrawn.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT00949377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00949377.